Discontinuation report PMS-CELECOXIB
| Report ID | 166939 |
| Drug Identification Number | 02355450 |
| Brand name | PMS-CELECOXIB |
| Common or Proper name | CELECOXIB |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CELECOXIB |
| Strength(s) | 200MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | M01AH |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2022-08-16 |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Please note that the 100mg is available pmsc-Celecoxib 100mg |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2022-08-18 | French | Compare |
| v4 | 2022-08-18 | English | Compare |
| v3 | 2022-08-18 | French | Compare |
| v2 | 2022-08-18 | English | Compare |
| v1 | 2022-08-18 | English | Compare |
Showing 1 to 5 of 5